ROCHE NIMBLEGEN
Roche NimbleGen provides products and services to the life science research market. The company offers SeqCap EZ system, a solution-based capture system that enables enrichment of exome in a single test tube; SeqCap EZ library that covers exome designs, gene panels, and custom content designs; and SeqCap EZ reagents to maximize workflow and order different reagent needs. It also provides SeqCap Epi, an enrichment system that includes a set of target enrichment tools for DNA methylation asse... ssment at single-base resolution, as well as offers SeqCap Epi kits and reagents. The company provides a set of preparation and adapter kits for library construction including SignalMap, a software product for browsing of genomic tracks; and NimbleDesign, an online tool that enables users to design SeqCap EZ choice libraries. It offers DNA microarray products and services for CGH, ChIP-chip, DNA methylation, AccuSNP, CGS, instruments, sequence capture arrays, gene expression microarrays, and their associated workflows. The company also provides online technical and instruction support services. Roche NimbleGen was founded in 1999 and is headquartered in Madison, Wisconsin. As of August 8, 2007, Roche NimbleGen operates as a subsidiary of Roche Holding AG.
ROCHE NIMBLEGEN
Industry:
Biotechnology Genetics Health Care Life Science Market Research
Founded:
1999-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.nimblegen.com
Total Employee:
10001+
Status:
Active
Contact:
+41 61 688 11 11
Total Funding:
43.95 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Molecular Cloning Laboratories
MCLAB offers genomic research consumables and services to the life science community.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Current Advisors List
Founder
Investors List
Topspin Partners
Topspin Partners investment in Series F - Roche NimbleGen
Cargill Ventures
Cargill Ventures investment in Series F - Roche NimbleGen
Venture Investors
Venture Investors investment in Series F - Roche NimbleGen
Baird Capital
Baird Capital investment in Series F - Roche NimbleGen
State of Wisconsin Investment Board
State of Wisconsin Investment Board investment in Series D - Roche NimbleGen
Tactics II Investments
Tactics II Investments investment in Series D - Roche NimbleGen
Schott
Schott investment in Series D - Roche NimbleGen
Baird Capital
Baird Capital investment in Series D - Roche NimbleGen
Venture Investors
Venture Investors investment in Series D - Roche NimbleGen
Skyline Ventures
Skyline Ventures investment in Series D - Roche NimbleGen
More informations about "Roche NimbleGen"
Nimblegen - Genomics.org
F. Hoffmann–La Roche, Ltd. acquired Nimblegen. It is a Swiss global health-care company which operates world-wide under two divisions: Pharmaceuticals and Diagnostics. It belongs to the …See details»
Roche NimbleGen - Crunchbase Company Profile
Roche NimbleGen was founded in 1999 and is headquartered in Madison, Wisconsin. As of August 8, 2007, Roche NimbleGen operates as a subsidiary of Roche Holding AG.See details»
Roche NimbleGen Company Profile 2024: Valuation, …
Manufacturer and marketer of a proprietary suite of microarrays, related products and services for DNA sequencing. The company is focused on research activities and manufacturing target-enrichment probe pools for DNA sequencing.See details»
Roche NimbleGen Inc. - LinkedIn
Roche NimbleGen is an innovator in the life sciences market, working with an integrated team among Roche Applied Science researchers worldwide. Our site in Madison, WI is focused on research...See details»
Roche NimbleGen and BGI Develop Advanced MHC Region …
Nov 28, 2011 · Roche NimbleGen, Inc. and BGI, the world's largest genomic organization, announced that they have developed a Major Histocompatibility Complex (MHC) region …See details»
Roche Nimblegen, Inc. Company Profile - Dun & Bradstreet
Company Description: Roche NimbleGen displays agility in testing DNA. Formerly NimbleGen Systems, the company develops products and services for the analysis of genomes, which …See details»
Roche Will Acquire NimbleGen - Chemical & Engineering News
Jun 25, 2007 · Roche will purchase NimbleGen Systems for $273 million in an attempt to build its position in the genomics research market. Just last month, Roche completed a $155 million …See details»
Roche Acquires Nimblegen to Gain Entry into High-Growth …
Jun 19, 2007 · Roche and NimbleGen Systems Inc. has announced that they have signed a definitive agreement under which Roche will acquire 100% of NimbleGen, a privately held, …See details»
Roche to Acquire NimbleGen Systems for $272.5M in Cash
Jun 19, 2007 · Looking to strengthen its position in the genomics research market, Roche will acquire NimbleGen Systems for $272.5 million in cash, the firms said this week. The …See details»
Roche to Acquire NimbleGen for $272.5M, Eyes Additional …
Jun 19, 2007 · NimbleGen, a private company based in Madison, Wisc., in March filed with the US Securities and Exchange Commission to file an initial public offering of stock but had not set a …See details»
Roche NimbleGen - Funding, Financials, Valuation & Investors
Roche NimbleGen provides products and services to the life science research market.See details»
Roche NimbleGen Launches NimbleGen Sequence Capture …
Apr 1, 2008 · Roche NimbleGen, a company of Roche Applied Science announced the commercial launch of its NimbleGen Sequence Capture technology for scientists interested in …See details»
Roland Green, Niblegen Systems Co-founder — How They Did It
Jan 4, 2021 · Roland Green co-founded NimbleGen Systems, to commercialize the Maskless Array Synthesizer (MAS) technology that Dr. Green co-invented as his thesis project.See details»
Roche NimbleGen’s Revolutionary Sequence Capture Technology …
Sep 5, 2008 · Earlier this year, Roche NimbleGen announced the launch of their Sequence Capture Technology, a groundbreaking technique for enriching targeted genomic regions for …See details»
Roche to Close NimbleGen Site, Lay Off 79 by Mid-2020
Jun 22, 2018 · Roche acquired NimbleGen Systems in 2007 for $272.5 million. NimbleGen was founded in 1999, based on maskless array synthesis technology developed at the University of …See details»
NimbleGen - Products, Competitors, Financials, Employees, …
NimbleGen is a supplier of customized high-density microarray products and services, offering unprecedented flexibility for genomics research. Use the CB Insights Platform to explore …See details»
Nimble Therapeutics spins out of Roche, saving Madison jobs
Oct 29, 2024 · A new drug discovery and development company is taking root in Madison, and it will prevent more than a dozen skilled scientists here from losing their jobs. Nimble …See details»
Hybridization-Based Target Enrichment - Sequencing
Explore the KAPA target enrichment portfolio. KAPA HyperExome Probes cover the CCDS, RefSeq, Ensembl, GENCODE and ClinVar genomic databases in an efficient ~43 Mb capture …See details»
GEO Accession viewer - National Center for Biotechnology …
Sep 27, 2011 · NimbleGen: Manufacture protocol: High-density DNA array prepared with Maskless Array Synthesizer (MAS) technology. See manufacturer's website at …See details»
GEO Accession viewer - National Center for Biotechnology …
Jul 1, 2013 · NCBI's Gene Expression Omnibus (GEO) is a public archive and resource for gene expression data.See details»